Nutrastar marks steady revenue in Q2, 2015

Singapore: China based healthcare product supplier, Nutrastar International, has marked revenue of $13.24 million in thr...

August 14, 2015 | Friday | Company results
WuXi Healthcare Ventures raises $290M

WuXi Healthcare Ventures announced the closing of its $290 million WuXi Healthcare Ventures II,exceeding its initial tar...

December 17, 2015 | Thursday | News
Is India losing to China in the investment race?

While both India and China - both have a billion plus population - present similar pictures in terms of opportunities an...

May 17, 2012 | Thursday | Analysis
WuXi AppTec, Fudan Uni to jointly research on genomics

Singapore: China's WuXi AppTec has partnered with Fudan University to bring WuXi NextCODE's population human genomics da...

June 8, 2015 | Monday | News
Start-up landscape in Southeast Asia

Singapore: The findings are surprising, mentions BVGH, as often it is the big pharmaceutical companies that invest larg...

April 30, 2015 | Thursday | Analysis
Asian firms lack antibody manufacturing capabilities

There are very few manufacturers in Asia capable of manufacturing antibodies on a large commercial scale. Manufacturing ...

October 4, 2012 | Thursday | Analysis
China hep B market to touch $1.4 bn by 2024'

Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 mill...

March 1, 2016 | Tuesday | Analysis
BioSpectrum award winner Biomics uses RNAi for therapeutics

Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interfer...

March 15, 2013 | Friday | Influencers
Heartbeat Experts expands in BRICK

Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, ann...

December 13, 2012 | Thursday | News
Kotaro Yoshida: China, Japan are the new M&A hot spots

Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...

June 12, 2013 | Wednesday | Opinion
Taiwan, China firms to develop novel cancer molecule

Singapore: Taiwan-based GNT Biotech has got exclusive license from China-based Shenzhen Chipscreen Biosciences for the d...

October 10, 2013 | Thursday | News
Dyax, CVie to commercialize Kalbitor in China, HK

Singapore: Dyax and CVie Therapeutics, a subsidiary of Lee's Pharmaceutical Holdings, announced a strategic partnership...

February 8, 2013 | Friday | News
China: Is this an end to foreign monopoly?

Singapore: With 1.3 billion population and a burgeoning middle class, China has witnessed an unprecedented increase in ...

March 4, 2015 | Wednesday | Analysis
Amgen to open R&D units in Chinese univ

Singapore: Amgen and ShanghaiTech University, China, entered into a memorandum of understanding (MoU) to form a strategi...

September 26, 2013 | Thursday | News
China Health Resource expands its 'Go Global Initiative'

Singapore: China Health Resource (CHRI) is expanding the company's Go Global Initiative to include the migraine market a...

July 20, 2012 | Friday | News
M&A fuels the Medtech sector

Singapore: Mergers and acquisitions in the medical device sector in 2014 touched the peak in terms of value when medtec...

March 6, 2015 | Friday | Analysis
UK's Rex Bionics enters China market

Singapore: London-based Rex Bionics has inked a partnership agreement with Chinese investment and trading company MAAB G...

July 21, 2015 | Tuesday | News
China's Sinovac progresses to launch new vaccines

Singapore: China's biopharmaceutical firm, Sinovac Biotech, is progressing on its pipeline vaccines and expects to bring...

March 18, 2015 | Wednesday | News